Thieme Chemistry and the Editors of Science of Synthesis announce the Margaret Faul Women in Chemistry Prize 2021.

General Principles:

• The prize is awarded to a young woman of any nationality within the first 15 years of her independent career in chemical research.
• The prize will be awarded in recognition of the candidate’s outstanding achievements in organic chemistry, broadly defined to include medicinal, biological, organometallic, or materials chemistry, and related areas.
• The prize includes an award of 5.000€.

Science of Synthesis and Thieme Chemistry are delighted to announce that the Dr Margaret Faul Women in Chemistry Award Winner 2021 is Cristina Nevado from University of Zurich (Switzerland)who is acknowledged as a rising star in the field of synthetic organic chemistry. She is recognized as an outstanding recipient of the award due to the breadth and diversity of her work which spans the development of new catalytic methods and elucidation of underlying mechanisms, important contributions in the synthesis of medicinally relevant natural products, and development of bioactive chemical probes.

The award will be presented to her at the European Symposium on Organic Chemistry Virtual Mini Symposium on Monday, July 5, 2021.

Margaret Faul is Vice President of Drug Product Technologies at Amgen Inc, in Thousand Oaks, CA. She is responsible to develop the commercial processes for modalities within the Amgen portfolio from preclinical to commercial and has a strong knowledge of GMP, regulatory and compliance issues as they relate to the development of these pharmaceutical products.

Margaret received her B.Sc. and M.Sc degrees from University College Dublin, Ireland. In 1987 she moved to the United States where she received her Ph.D. degree in Synthetic Organic Chemistry from Harvard University with Professor David A. Evans. In 1993 Margaret joined the Chemical Process group at Eli Lilly and Company and in 2003 went to Amgen Inc, in Thousand Oaks, CA where she is currently Vice President of Drug Product Technologies within the Process Development organization.

During her 25-year career Margaret has leveraged her technical experience to support programs across all stages of development from preclinical to commercial focused on the process development and supply of drug substance and drug product for clinical trials and the commercial market. Margaret has experience working with Commercial Manufacturing Organizations worldwide and an ability to work with partners during licensing activities to ensure seamless integration and development of programs with the partner company. Margaret has a strong knowledge of GMP, regulatory and compliance issues as they relate to the development of pharmaceutical products. Margaret has received numerous awards in recognition of her leadership and mentorship including the Earle B. Barnes Award for Leadership in Chemical Research Management from Dow Chemical Company and the American Chemical Society and a HBA Rising Star Award.

(...) Read the full portrait of Dr Margaret Faul here